Plain-English summary: 5-Amino-1MQ and AOD-9604 both target fat without touching appetite
BACKGROUND: Incretin-based therapies such as glucagon-like peptide-1 receptor agonists (GLP-1Ras), dual GLP-1/GIP agonists and amylin analogues have demonstrated significant weight loss benefits
10.1126/sciadv.1701679 146 QosaH.LichterJ.SarloM.MarkandaiahS
Ongoing phase 3 trials are in progress, and CagriSema is currently under FDA review, with a decision expected in late 2026
With proper sterile technique, you can continue sampling from the same vial for 3+ months the standard "discard after 28 days" disclaimer is an FDA bacteriostatic labeling requirement, not a reflection of peptide efficacy
Each 10 mL multi-dose vial contains 100 mcg/mL of Vitamin B12, equivalent to ten 1 mL weekly injections, making it a convenient and cost-effective option for patients requiring regular supplementation